0 min read(BPRW) Vivacelle Bio Announces Early Results of its Phase IIa Clinical Trial of VBI-S for Improving Hypovolemia Due to Sepsis
Sepsis is to blame for the 40-year-old mother's unexpected death. It sheds light on broader maternal healthcare issues for Black women.https://21ninety.com/krystal-anderson-sepsis-death-stillbirth
Vivacelle Bio and University of Missouri-Kansas City School of Medicine Announce Groundbreaking Results from Phase 2a Clinical Trial of VBI-S for Refractory Hypotension in Severe Septic Shock Patients